Fountain Therapeutics Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Series A2
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 7

Fountain Therapeutics General Information

Description

Developer of therapeutics designed to decouple aging from disease and significantly extend human healthspan. The company's therapeutics offers a transformative model of ageing that re-creates many of the complex hallmark features of ageing and combines the powerful cellular model with artificial intelligence and computer vision to develop a disruptive unbiased platform for the identification of novel targets and potential therapeutics, enabling doctors to treat ageing diseases.

Contact Information

Website
www.fountaintx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • 681 Gateway Boulevard
  • San Francisco, CA 94080
  • United States

Fountain Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Fountain Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A2) 18-Nov-2021 $15M 0000 0000 Completed Generating Revenue
3. Early Stage VC (Series A1) 19-Feb-2020 000 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 07-May-2018 $5M $5M 000.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Fountain Therapeutics’s complete valuation and funding history, request access »

Fountain Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 7,998,720 $0.001000 8% $0.63 $0.63 1x $0.63 18.54%
To view Fountain Therapeutics’s complete cap table history, request access »

Fountain Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapeutics designed to decouple aging from disease and significantly extend human healthspan. The company
Drug Discovery
San Francisco, CA
13 As of 2021
0000
000 0000-00-00
00000000000 0000

000000

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
0000 000000000
Richmond, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000 0

sectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000000000000
Alameda, CA
000.00
0000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Fountain Therapeutics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioAge Venture Capital-Backed Richmond, CA 00 00000 00000000000 00000
000000 00000000000 Angel-Backed Alameda, CA 000.00 0000000000 000.00
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 0000 00000000000 0000
00000 000000000000 Formerly VC-backed San Francisco, CA 00 00000 000000 - 000 00000
To view Fountain Therapeutics’s complete competitors history, request access »

Fountain Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Joseph Rodgers Ph.D Co-Founder & Director of Biology
Thomas Rando Ph.D Co-Founder & Chairman
Tom Cheung Co-Founder
William Greene MD Chief Executive Officer
Anupama Hoey Chief Business Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Fountain Therapeutics Board Members (3)

Name Representing Role Since
Ashish Khanna Fountain Therapeutics Board Member 000 0000
Thomas Rando Ph.D Fountain Therapeutics Co-Founder & Chairman 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Fountain Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Fountain Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Eli Lilly and Company Foundation Limited Partner Minority 000 0000 000000 0
R42 Group Venture Capital Minority 000 0000 000000 0
Eshelman Ventures Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial